Multimodality imaging of endothelial progenitor cells with a novel multifunctional probe featuring positive magnetic resonance contrast and near-infrared fluorescence

Molecular Imaging

Volumn 10, Issue 5, 2011, Pages 359-369

  Ju, Shenghong ^a   Qiu, Yiru ^b   Li, Cong ^c   Teng, Gao Jun ^a   Ni, Yicheng ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL VIABILITY; CELLULAR UPTAKE; ENDOTHELIAL PROGENITOR CELLS; HIGH SENSITIVITY; IMAGING PROBE; IN-VIVO; LIVE CELL; MULTI-MODAL; MULTIMODAL IMAGING; MULTIMODALITY IMAGING; NEAR-INFRARED FLUORESCENCE; PERIPHERAL BLOOD; PRELIMINARY DATA; SPATIAL RESOLUTION; T1-WEIGHTED MAGNETIC RESONANCE IMAGING; TIME-DEPENDENT;

CONTRAST MEDIA; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; INFRARED DEVICES; PROBES;

MAGNETIC RESONANCE IMAGING;

CODA PROTEIN, E COLI; CYTOSINE DEAMINASE; ESCHERICHIA COLI PROTEIN; FLUORESCENT DYE;

ANIMAL; ARTICLE; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; ENDOTHELIUM CELL; FLOW CYTOMETRY; INSTRUMENTATION; KINETICS; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; STEM CELL;

ANIMALS; CELL SURVIVAL; CYTOSINE DEAMINASE; ENDOTHELIAL CELLS; ESCHERICHIA COLI PROTEINS; FLOW CYTOMETRY; FLUORESCENT DYES; KINETICS; MAGNETIC RESONANCE IMAGING; MICROSCOPY, CONFOCAL; RABBITS; SPECTROSCOPY, NEAR-INFRARED; STEM CELLS;

EID: 80053026275     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00055     Document Type: Article

References (39)

1. Koo V, Hamilton PW, Williamson K. Non-invasive in vivo imaging in small animal research. Cell Oncol 2006;28:127-39. (Pubitemid 44427396)
2. Wagenaar DJ, Kapusta M, Li J, et al. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging. Technol Cancer Res Treat 2006;5:343-50. (Pubitemid 44300250)
3. Achilefu S. Lighting up tumors with receptor-specific optical molecular probes. Technol Cancer Res Treat 2004;3:393-409. (Pubitemid 39096612)
4. Riviere C, Boudghene FP, Gazeau F, et al. Iron oxide nanoparticlelabeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. Radiology 2005;235:959-67, doi:10.1148/radiol.2353032057. (Pubitemid 40695895)
5. Kostura L, Kraitchman DL, Mackay AM, et al. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004;17:513-7, doi:10.1002/ nbm.925. (Pubitemid 39549429)
6. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004;17:484-99, doi:10.1002/nbm.924. (Pubitemid 39549426)
7. Daldrup-Link HE, Rudelius M, Metz S, et al. Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur J Nucl Med Mol Imaging 2004;31:1312-21. (Pubitemid 39222496)
8. Rudelius M, Daldrup-Link HE, Heinzmann U, et al. Highly efficient paramagnetic labelling of embryonic and neuronal stem cells. Eur J Nucl Med Mol Imaging 2003;30:1038-44, doi:10.1007/ s00259-002-1110-0. (Pubitemid 37086949)
9. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-9, doi:10.1161/01.ATV.0000073832.49290.B5. (Pubitemid 36871271)
10. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007, doi:10.1056/NEJMoa043814. (Pubitemid 41262334)
11. Moore MA. Putting the neo into neoangiogenesis. J Clin Invest 2002;109:313-5. (Pubitemid 34141804)
12. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional smalldiameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035-40, doi:10.1038/nm0901- 1035. (Pubitemid 32937384)
13. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-35, doi:10.1016/ S0140-6736(02)09670-8.
14. Anderson SA, Lee KK, Frank JA. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol 2006;41:332-8, doi:10.1097/01.rli.0000192420.94038.9e. (Pubitemid 44406195)
15. Li C, Winnard PT Jr, Takagi T, et al. Multimodal image-guided enzyme/prodrug cancer therapy. J Am Chem Soc 2006;128:15072-3, doi:10.1021/ja066199i. (Pubitemid 44853505)
16. Aoki M, Yasutake M, Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004;22:994-1002, doi:10.1634/ stemcells.22-6-994. (Pubitemid 39507086)
17. Mai XL, Ma ZL, Sun JH, et al. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant 2009;18:171-81, doi:10.3727/09636890 9788341306.
18. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002;17:803-11, doi:10.1016/S1053-8119(02)91194-8. (Pubitemid 35317014)
19. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 1999;96:15256-61, doi:10.1073/pnas.96.26. 15256. (Pubitemid 30019799)
20. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-14, doi:10.1161/01.CIR.0000084537.66419.7A. (Pubitemid 37048233)
21. Ju S, Teng GJ, Lu H, et al. In vivo MR tracking of mesenchymal stem cells in rat liver after intrasplenic transplantation. Radiology 2007;245:206-15, doi:10.1148/radiol.2443061290. (Pubitemid 47417804)
22. Sun JH, Teng GJ, Ju SH, et al. MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure. Cell Transplant 2008;17:279-90, doi:10.3727/096368908784153878.
23. Himmelreich U, Weber R, Ramos-Cabrer P, et al. Improved stem cell MR detectability in animal models by modification of the inhalation gas. Mol Imaging 2005;4:104-9. (Pubitemid 43143797)
24. Granot D, Kunz-Schughart LA, Neeman M. Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging. Magn Reson Med 2005; 54:789-97, doi:10.1002/mrm.20628. (Pubitemid 41457049)
25. Himmelreich U, Aime S, Hieronymus T, et al. A responsive MRI contrast agent to monitor functional cell status. Neuroimage 2006; 32:1142-9, doi:10.1016/j.neuroimage.2006.05.009. (Pubitemid 44294776)
26. Mahan SD, Ireton GC, Knoeber C, et al. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 2004;17:625-33, doi:10.1093/protein/ gzh074. (Pubitemid 39665399)
27. Uzgiris E. The role of molecular conformation on tumor uptake of polymeric contrast agents. Invest Radiol 2004;39:131-7, doi:10.1097/01.rli. 0000107495.48025.97. (Pubitemid 38263918)
28. Misselwitz B, Platzek J, Weinmann HJ. Early MR lymphography with gadofluorine M in rabbits. Radiology 2004;231:682-8, doi:10.1148/radiol. 2313021000. (Pubitemid 38668083)
29. Li C, Wildes F, Winnard P, et al. Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/ prodrug cancer therapy. J Med Chem 2008;51:3572-82, doi:10.1021/jm800288h. (Pubitemid 351875012)
30. Hong S, Leroueil PR, Janus EK, et al. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 2006;17:728-34, doi:10.1021/bc060077y. (Pubitemid 43794383)
31. Shah N, Cerussi A, Eker C, et al. Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci U S A 2001;98:4420-5, doi:10.1073/pnas.071511098. (Pubitemid 32294992)
32. Koyama Y, Hama Y, Urano Y, et al. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res 2007;13:2936-45, doi:10.1158/1078-0432.CCR-06- 2240. (Pubitemid 46849568)
33. Hama Y, Koyama Y, Choyke PL, et al. Two-color in vivo dynamic contrast-enhanced pharmacokinetic imaging. J Biomed Opt 2007; 12:034016, doi:10.1117/1.2745306. (Pubitemid 47249779)
34. Bremer C, Tung CH, Bogdanov A, et al. Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 2002;222:814-8, doi:10.1148/ radiol.2223010812. (Pubitemid 34218157)
35. Koyama Y, Barrett T, Hama Y, et al. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. Neoplasia 2007;9:1021-9, doi:10.1593/neo.07787. (Pubitemid 350255349)
36. Pham W, Xie J, Gore JC. Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia 2007;9:1130-7, doi:10.1593/ neo.07586. (Pubitemid 350255360)
37. Zhang GJ, Chen TB, Bednar B, et al. Optical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validation. Neoplasia 2007;9:652-61, doi:10.1593/ neo.07421. (Pubitemid 47328084)
38. Pogue BW, Poplack SP, McBride TO, et al. Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 2001;218:261-6. (Pubitemid 32151305)
39. Ntziachristos V, Yodh AG, Schnall MD, et al. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 2002;4:347-54, doi:10.1038/sj.neo.7900244. (Pubitemid 34755845)